Effect of COVID-19 lockdown on Moroccan patients with type 1 and type 2 diabetes.

Background: The implementation of coronavirus disease of 2019 (COVID-19) lockdown has affected the daily practices of subjects with chronic diseases such as diabetes and caused negative impact on their lifestyle and habits such as physical activity, dietary habits and accessibility to medications. Diabetic people are considered the most vulnerable groups to COVID-19, and the lockdown measure has disturbed the diabetes self-management. In our study, we aimed to assess, for the first time at the regional level (Souss Massa Region), the COVID-19 lockdown impact on HbA1c levels in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D). We carried out a cross-sectional quantitative analysis at the health center of the industrial district in Agadir City.

Results: We found a significant improvement in post-lockdown mean ± SD HbA1c in 150 subjects suffering from T1D and T2D;  = 0.005). Our analysis revealed a significant association of HbA1c deviation with educational level and medical coverage ( = 0.01). No significant association was detected between HbA1c deviation and age, gender, weight, height, current BMI status, fasting blood sugar, family history, urban or rural areas, marital status, professional activity, socioeconomic income, type of diabetes, dietary, comorbidities, diabetic complications, housing, adherence to the dietary recommendations, physical activity, medical appointments, stopping medication, self-monitoring, fasting and anxiety about getting COVID-19.

Conclusions: COVID-19 lockdown had no deleterious effect on HbA1c levels in Moroccan patients with T1D and T2D.